PMID: 3355248Feb 1, 1988Paper

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

Annals of the Rheumatic Diseases
N J McHughP J Maddison


Increased levels of IgG anticardiolipin antibodies (ACA) were found in 23 of 98 patients (23%) with systemic lupus erythematosus. Increased levels of IgM ACA were found less frequently (5%). All four patients with major cerebrovascular events had increased IgG ACA, including the two with highest levels, both of whom were men. Six of nine patients with livedo reticularis had increased IgG ACA. In turn, this clinical feature was associated with cerebrovascular disease in two and renal disease in another six. IgG ACA were not associated with other thromboembolic events, thrombocytopenia, serum IgG, or autoantibodies to Ro(SSA), La(SSB), U1RNP, Sm, or double or single stranded DNA.


Apr 1, 1978·Annals of the Rheumatic Diseases·R GrigorG R Hughes
Oct 1, 1975·Annals of the Rheumatic Diseases·T Gibson, A R Myers
May 22, 1986·The New England Journal of Medicine·R LenziH Spiera
Nov 21, 1985·The New England Journal of Medicine·D W BranchE Hershgold
Jul 1, 1968·Medicine·R T Johnson, E P Richardson
Nov 10, 1984·Lancet·E N HarrisG R Hughes
Apr 1, 1984·British Journal of Obstetrics and Gynaecology·W F LubbeG C Liggins
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Apr 1, 1965·The British Journal of Dermatology·I B SNEDDON

❮ Previous
Next ❯


Jan 1, 1989·Rheumatology International·E Schulze-LohoffJ R Kalden
Oct 6, 2007·Clinical Reviews in Allergy & Immunology·E Toubi, Y Shoenfeld
Oct 16, 1993·Lancet·T EdwardsN J McHugh
Jun 1, 1991·Archives of Disease in Childhood·M A Montes de OcaB Wechsler
Aug 1, 1988·Annals of the Rheumatic Diseases·E BaguleyG R Hughes
May 1, 1990·Postgraduate Medical Journal·N SnowdenR S Pumphrey
Jan 1, 1991·Rheumatology International·A P van Dam
Jan 27, 2015·International Journal of Molecular Sciences·Elisabeth SchinnerJens Schlossmann
Apr 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C QueredaJ Ortuño
Feb 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M WilkowskiK McCabe
Jul 1, 1992·Clinical and Experimental Dermatology·R A AshersonG R Hughes
Oct 12, 2007·Kidney International·L Adalid-PeraltaS Koutouzov
Jan 1, 1991·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·N Futrell, C H Millikan
Nov 1, 1994·Journal of the American Academy of Dermatology·A D BurdenD M Tillman
Mar 4, 2008·Pathophysiology : the Official Journal of the International Society for Pathophysiology·N S NovikovaE A Korneva
Sep 21, 2007·Pathophysiology : the Official Journal of the International Society for Pathophysiology·T V AbramovaE A Korneva
Jan 1, 1990·The American Journal of Medicine
Feb 1, 1997·Journal of the American Academy of Dermatology·G T Nahass
Sep 6, 2001·Rheumatic Diseases Clinics of North America·M J Cuadrado, G R Hughes
Sep 29, 2006·Clinical and Experimental Dermatology·S KirkeN Simpson
Jun 4, 2005·Arthritis and Rheumatism·Camille FrancèsJean Charles Piette
Aug 1, 1988·Annals of the Rheumatic Diseases·R A Asherson, G R Hughes
Feb 1, 1989·The British Journal of Dermatology·R A AshersonG R Hughes
Dec 1, 1989·Arthritis and Rheumatism·N J McHugh, P J Maddison

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.